{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T18:06:47Z","timestamp":1784311607797,"version":"3.55.0"},"update-to":[{"DOI":"10.1371\/journal.pgen.1012230","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000}}],"reference-count":28,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosgenetics.org"],"crossmark-restriction":false},"short-container-title":["PLoS Genet"],"abstract":"<jats:p>\n                    The\n                    <jats:italic>C9orf72<\/jats:italic>\n                    hexanucleotide repeat expansion is the most common genetic cause of amyotrophic lateral sclerosis (ALS) or frontotemporal dementia (FTD). In genetic counseling, children of mutation carriers are often told that they have a 50% risk of carrying the mutation, but this figure does not take into account the fact that penetrance is age-related, with a unimodal distribution of disease onset around 58 years of age. Using a Bayesian approach, we developed a theory to calculate the probability of carrying the mutation for asymptomatic relatives (children\/siblings and grandchildren\/niblings) as well as the probability of developing ALS\/FDT within a given time frame, based on their age. Using published data on age-related penetrance, we then calculated these probabilities and developed an online simulator that makes it easy to calculate them on a case-by-case basis. The conditional probabilities obtained can be very different from Mendelian values. For example, a 70-year-old asymptomatic child born to a carrier has approximately a 6% risk of being a carrier, which is far from 50%. For grandchildren, taking into account both their age and that of their parents also leads to figures that are much lower than those obtained if only their age were considered. For consultands, the decision to undergo testing is based in part on risk estimates. In this regard, the refined estimates and simulator we propose may prove to be valuable tools for genetic counseling for families affected by ALS\/FTD linked to the\n                    <jats:italic>C9orf72<\/jats:italic>\n                    <jats:sup>RE<\/jats:sup>\n                    mutation. In addition, the formulas used in this study could also be used to calculate risk estimates for other diseases caused by autosomal dominant mutations with age-dependent penetrance.\n                  <\/jats:p>","DOI":"10.1371\/journal.pgen.1012230","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T17:41:28Z","timestamp":1783964488000},"page":"e1012230","update-policy":"https:\/\/doi.org\/10.1371\/journal.pgen.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Age-based risk estimates for C9orf72RE-related diseases: Theoretical developments and added value for genetic counseling"],"prefix":"10.1371","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3395-7901","authenticated-orcid":true,"given":"Dominique","family":"de Vienne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9532-5251","authenticated-orcid":true,"given":"Damien M.","family":"de Vienne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,7,13]]},"reference":[{"key":"pgen.1012230.ref001","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1093\/brain\/awr179","article-title":"Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia","volume":"134","author":"K Rascovsky","year":"2011","journal-title":"Brain"},{"issue":"8","key":"pgen.1012230.ref002","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1007\/s00415-019-09363-4","article-title":"An update on genetic frontotemporal dementia","volume":"266","author":"CV Greaves","year":"2019","journal-title":"J Neurol"},{"issue":"10","key":"pgen.1012230.ref003","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1111\/ene.14393","article-title":"Amyotrophic lateral sclerosis: a clinical review","volume":"27","author":"P Masrori","year":"2020","journal-title":"Eur J Neurol"},{"issue":"2","key":"pgen.1012230.ref004","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.neuron.2011.09.011","article-title":"Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS","volume":"72","author":"M DeJesus-Hernandez","year":"2011","journal-title":"Neuron"},{"issue":"2","key":"pgen.1012230.ref005","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.neuron.2011.09.010","article-title":"A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD","volume":"72","author":"AE Renton","year":"2011","journal-title":"Neuron"},{"issue":"3","key":"pgen.1012230.ref006","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.ajhg.2013.01.011","article-title":"Large C9orf72 hexanucleotide repeat expansions are seen in multiple neurodegenerative syndromes and are more frequent than expected in the UK population","volume":"92","author":"J Beck","year":"2013","journal-title":"Am J Hum Genet"},{"issue":"6","key":"pgen.1012230.ref007","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1097\/WCO.0b013e32835a3efb","article-title":"How do C9ORF72 repeat expansions cause amyotrophic lateral sclerosis and frontotemporal dementia: can we learn from other noncoding repeat expansion disorders?","volume":"25","author":"M van Blitterswijk","year":"2012","journal-title":"Curr Opin Neurol"},{"issue":"2","key":"pgen.1012230.ref008","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3233\/JAD-121456","article-title":"C9ORF72 repeat expansions in the frontotemporal dementias spectrum of diseases: a flow-chart for genetic testing","volume":"34","author":"I Le Ber","year":"2013","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"pgen.1012230.ref009","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1038\/s41598-017-02364-1","article-title":"Age-related penetrance of the C9orf72 repeat expansion","volume":"7","author":"NA Murphy","year":"2017","journal-title":"Sci Rep"},{"issue":"1","key":"pgen.1012230.ref010","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1086\/301670","article-title":"Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2","volume":"62","author":"G Parmigiani","year":"1998","journal-title":"Am J Hum Genet"},{"key":"pgen.1012230.ref011","doi-asserted-by":"crossref","DOI":"10.2202\/1544-6115.1063","article-title":"BayesMendel: an R environment for Mendelian risk prediction","volume":"3","author":"S Chen","year":"2004","journal-title":"Stat Appl Genet Mol Biol"},{"issue":"8","key":"pgen.1012230.ref012","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1038\/s41436-018-0406-9","article-title":"BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors","volume":"21","author":"A Lee","year":"2019","journal-title":"Genet Med"},{"issue":"3","key":"pgen.1012230.ref013","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1158\/1055-9965.EPI-20-1319","article-title":"CanRisk Tool-A Web Interface for the Prediction of Breast and Ovarian Cancer Risk and the Likelihood of Carrying Genetic Pathogenic Variants","volume":"30","author":"T Carver","year":"2021","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"5","key":"pgen.1012230.ref014","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s10897-018-0238-4","article-title":"A Clinical Decision Support Tool to Predict Cancer Risk for Commonly Tested Cancer-Related Germline Mutations","volume":"27","author":"D Braun","year":"2018","journal-title":"J Genet Couns"},{"issue":"4","key":"pgen.1012230.ref015","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1111\/j.1541-0420.2006.00614.x","article-title":"A method for estimating penetrance from families sampled for linkage analysis","volume":"62","author":"Y Wang","year":"2006","journal-title":"Biometrics"},{"issue":"1","key":"pgen.1012230.ref016","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s10897-006-9040-9","article-title":"Bayesian risk assessment in genetic testing for autosomal dominant disorders with age-dependent penetrance","volume":"16","author":"S Ogino","year":"2007","journal-title":"J Genet Couns"},{"issue":"3","key":"pgen.1012230.ref017","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1590\/S1415-47572012005000051","article-title":"Penetrance rate estimation in autosomal dominant conditions","volume":"35","author":"PA Otto","year":"2012","journal-title":"Genet Mol Biol"},{"issue":"24","key":"pgen.1012230.ref018","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1212\/WNL.0000000000002773","article-title":"Presymptomatic ALS genetic counseling and testing: Experience and recommendations","volume":"86","author":"M Benatar","year":"2016","journal-title":"Neurology"},{"issue":"1","key":"pgen.1012230.ref019","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000000542","article-title":"C9orf72 and the Care of the Patient With ALS or FTD: Progress and Recommendations After 10 Years","volume":"7","author":"J Roggenbuck","year":"2020","journal-title":"Neurol Genet"},{"issue":"1","key":"pgen.1012230.ref020","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s13073-022-01142-7","article-title":"Calculating variant penetrance from family history of disease and average family size in population-scale data","volume":"14","author":"TP Spargo","year":"2022","journal-title":"Genome Med"},{"issue":"2","key":"pgen.1012230.ref021","article-title":"Personalised penetrance estimation for C9orf72-related amyotrophic lateral sclerosis and frontotemporal dementia","volume":"6","author":"AGL Douglas","year":"2024","journal-title":"BMJ Neurol Open"},{"key":"pgen.1012230.ref022","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1080\/21678421.2023.2272187","article-title":"Assessment of risk of ALS conferred by the GGGGCC hexanucleotide repeat expansion in C9orf72 among first-degree relatives of patients with ALS carrying the repeat expansion","volume":"25","author":"IF Van Wijk","year":"2024","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"11","key":"pgen.1012230.ref023","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.1038\/s41591-024-03190-5","article-title":"Increased frequency of repeat expansion mutations across different populations","volume":"30","author":"K Iba\u00f1ez","year":"2024","journal-title":"Nat Med"},{"issue":"4","key":"pgen.1012230.ref024","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S1474-4422(12)70043-1","article-title":"Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study","volume":"11","author":"E Majounie","year":"2012","journal-title":"Lancet Neurol"},{"issue":"2","key":"pgen.1012230.ref025","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S1474-4422(19)30394-1","article-title":"Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study","volume":"19","author":"KM Moore","year":"2020","journal-title":"Lancet Neurol"},{"key":"pgen.1012230.ref026","doi-asserted-by":"crossref","first-page":"316","DOI":"10.3389\/fnins.2020.00316","article-title":"Clinical Phenotype and Inheritance in Patients With C9ORF72 Hexanucleotide Repeat Expansion: Results From a Large French Cohort","volume":"14","author":"F Esselin","year":"2020","journal-title":"Front Neurosci"},{"issue":"9","key":"pgen.1012230.ref027","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1038\/s41588-024-01842-3","article-title":"Guidance for estimating penetrance of monogenic disease-causing variants in population cohorts","volume":"56","author":"CF Wright","year":"2024","journal-title":"Nat Genet"},{"issue":"3","key":"pgen.1012230.ref028","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1136\/jmg-2023-109580","article-title":"Reduced penetrance of gene variants causing amyotrophic lateral sclerosis","volume":"61","author":"AGL Douglas","year":"2024","journal-title":"J Med Genet"}],"updated-by":[{"DOI":"10.1371\/journal.pgen.1012230","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000}}],"container-title":["PLOS Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pgen.1012230","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T18:01:43Z","timestamp":1784311303000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pgen.1012230"}},"subtitle":[],"editor":[{"given":"Heather J","family":"Cordell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,7,13]]},"references-count":28,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pgen.1012230","relation":{},"ISSN":["1553-7404"],"issn-type":[{"value":"1553-7404","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,13]]}}}